Our best pick

Apollo Care

In short

Apollo Care is a 503B outsourcing facility based in Columbia, MO. A government record names semaglutide and tirzepatide at Apollo Care; the newest is an FDA recall dated July 29, 2026. It fills prescriptions; it doesn’t write them, so you can’t get a GLP-1 from Apollo Care without a prescription from a licensed clinician.1

How to get a GLP‑1 filled by Apollo Care

Checked November 20, 2026 against FDA, CMS and state board records. Every fact links to its source.

Apollo Care at a glance

FactWhat the records show
What it is503B outsourcing facility2
Based in3801 Mojave Ct, Ste 101, Columbia, MO
NPI number1124566989
State licensesMO 2017002680As reported to the NPI Registry; the state board is the authority.21
FDA 503B registerRegistered since September 14, 2017; last inspected July 28, 2026; a Form 483 was issued2
Websiteapollocare.net

How to get a GLP‑1 filled by Apollo Care

To get a GLP‑1 from Apollo Care, you first need a prescription: it fills prescriptions; it doesn’t write them or sell without one. An online program takes you through the steps: you fill in a health questionnaire, a licensed clinician reviews it, and if they prescribe, the program’s pharmacy ships the medication to you.

These are the three programs ranked highest on our score. Check that a program ships to your state before you sign up.

  1. 1Health questionnaire, online
  2. 2A licensed clinician decides
  3. 3The pharmacy ships to you

We may earn a commission when you sign up through some links. It never changes our order or scores. How we make money

  1. Our top pickEmbodyOur score 9.6/10
    From
    $53/mo
    Its pharmacies
    Red Rock Compounding Pharmacy, Health Warehouse and 2 more
    See plans at EmbodyOpens joinem.co · Partner link
  2. CollectiveOur score 9.3/10
    From
    $76/mo
    See plans at CollectiveOpens collective.org · Partner link
  3. YourEraOur score 9.3/10
    From
    $65/mo
    Its pharmacies
    Galleria Medical Pharmacy, MediVera Compounding Pharmacy (Diversified Pharmacy, Inc.) and 1 more
    See plans at YourEraOpens yourera.com · Partner link

Prefer your own clinician? You’re free to: ask them to send your prescription to Apollo Care or another licensed pharmacy.

See every program we rank

What ties Apollo Care to GLP‑1s

  1. FDA recallJuly 29, 2026 · semaglutideClass II recall D-0755-2026: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material3
    “SEMAGLUTIDE 7.5mg (5mg/mL), Glycine 7.5 mg (5mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-721-01”
  2. FDA recallJuly 29, 2026 · semaglutideClass II recall D-0747-2026: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material4
    “SEMAGLUTIDE 12.5MG (2.5MG/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-495-05”
  3. FDA recallJuly 29, 2026 · semaglutideClass II recall D-0748-2026: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material5
    “SEMAGLUTIDE 2.25MG (0.9 mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202 NDC 71170-811-02”
  4. FDA recallJuly 29, 2026 · semaglutideClass II recall D-0753-2026: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material6
    “SEMAGLUTIDE 2.5mg (1mg/mL), Glycine 12.5 mg (5mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-711-02”
  5. FDA recallJuly 29, 2026 · semaglutideClass II recall D-0749-2026: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material7
    “SEMAGLUTIDE 6.75mg (4.5 mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202 NDC 71170-821-01”
  6. FDA recallJuly 29, 2026 · semaglutideClass II recall D-0752-2026: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material8
    “SEMAGLUTIDE 0.9mg (0.9 mg/mL), 1 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-810-01”
  7. FDA recallJuly 29, 2026 · semaglutideClass II recall D-0757-2026: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material9
    “SEMAGLUTIDE 20mg (5mg/mL), Glycine 20 mg (5mg/mL), 4 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-724-04.”
  8. FDA recallJuly 29, 2026 · semaglutideClass II recall D-0756-2026: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material10
    “SEMAGLUTIDE 10mg (5mg/mL), Glycine 10 mg (5mg/mL), 2 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-722-02”
  9. FDA recallJuly 29, 2026 · semaglutideClass II recall D-0751-2026: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material11
    “SEMAGLUTIDE 9mg (4.5 mg/mL), 2 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-822-02”
  10. FDA recallJuly 29, 2026 · semaglutideClass II recall D-0750-2026: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material12
    “SEMAGLUTIDE 4.5mg (0.9 mg/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-812-03”
  11. FDA recallJuly 29, 2026 · semaglutideClass II recall D-0754-2026: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material13
    “SEMAGLUTIDE 5mg (1mg/mL), Glycine 25 mg (5mg/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202.NDC 71170-712-03”
  12. FDA inspection report (Form 483)July 28, 2026 · semaglutide and tirzepatideFDA Form 483 inspectional observations, Apollo Care LLC, issued 2026-07-2814
    “reviewed retain samples of Semaglutide Injection and Semaglutide with Glycine Injection drug product vials”

Apollo Care’s FDA record

DateWhat the FDA did
July 28, 2026483 Issued 07/28/202614
February 2, 2026Warning Letter (02/02/2026)15
March 27, 2025483 Issued 03/27/202516
November 27, 2023Regulatory Meeting Held 11/27/2023
April 5, 2023483 Issued 04/05/202317
September 8, 2021483 Issued 09/8/202118
March 20, 2019Warning Letter (03/20/2019)19

What a compounded GLP‑1 is, and what it isn’t

The bigger question with any compounded program is the drug itself. Compounded GLP-1s are prepared by a pharmacy to a prescription. They are not FDA-approved: the FDA doesn’t review their safety, effectiveness or quality before they’re sold, and they are not the same as Wegovy or Zepbound. Formulas can differ from one pharmacy to the next, and some add ingredients such as vitamin B12.2324 Compounding pharmacies are licensed and inspected by state boards of pharmacy; outsourcing facilities (503B) also register with the FDA and are inspected by it. The FDA can issue warning letters when either breaks rules on safety or sterility.2220

Questions

Apollo Care: questions

Apollo Care is a 503B outsourcing facility. A 503A pharmacy compounds to a prescription for one patient and is licensed by its state board; a 503B outsourcing facility can compound larger batches and also registers with the FDA.

Not without a prescription. Apollo Care fills prescriptions that a licensed clinician writes, either a clinician near you or one working for an online program.

Yes. The FDA’s list of compounding actions shows 2 warning letters or close-outs, the newest dated February 2, 2026. A warning letter is an allegation the FDA has published, not a court finding.

Search the board of pharmacy’s license lookup in your state by the pharmacy’s name or license number. A pharmacy needs a license in each state it ships to.

No. Compounded GLP-1s are not FDA-approved and are not the same products as the brand-name drugs: the FDA doesn’t review their safety, effectiveness or quality before they’re sold.

Ready for a GLP‑1 prescription? Our top pick is Embody, scored 9.6/10.

See plans at EmbodyOpens joinem.co · Partner link

  1. 1.
    NPI Registry: APOLLO CARE, LLC (NPI 1124566989)Centers for Medicare & Medicaid Servicesretrieved 2026-11-20↩
  2. 2.
    Registered Outsourcing FacilitiesU.S. Food and Drug Administrationretrieved 2026-11-20↩
  3. 3.
    Class II recall D-0755-2026: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type materialU.S. Food and Drug Administration, Enforcement Report (openFDA)retrieved 2026-07-29↩“SEMAGLUTIDE 7.5mg (5mg/mL), Glycine 7.5 mg (5mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-721-01”
  4. 4.
    Class II recall D-0747-2026: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type materialU.S. Food and Drug Administration, Enforcement Report (openFDA)retrieved 2026-07-29↩“SEMAGLUTIDE 12.5MG (2.5MG/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-495-05”
  5. 5.
    Class II recall D-0748-2026: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type materialU.S. Food and Drug Administration, Enforcement Report (openFDA)retrieved 2026-07-29↩“SEMAGLUTIDE 2.25MG (0.9 mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202 NDC 71170-811-02”
  6. 6.
    Class II recall D-0753-2026: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type materialU.S. Food and Drug Administration, Enforcement Report (openFDA)retrieved 2026-07-29↩“SEMAGLUTIDE 2.5mg (1mg/mL), Glycine 12.5 mg (5mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-711-02”
  7. 7.
    Class II recall D-0749-2026: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type materialU.S. Food and Drug Administration, Enforcement Report (openFDA)retrieved 2026-07-29↩“SEMAGLUTIDE 6.75mg (4.5 mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202 NDC 71170-821-01”
  8. 8.
    Class II recall D-0752-2026: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type materialU.S. Food and Drug Administration, Enforcement Report (openFDA)retrieved 2026-07-29↩“SEMAGLUTIDE 0.9mg (0.9 mg/mL), 1 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-810-01”
  9. 9.
    Class II recall D-0757-2026: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type materialU.S. Food and Drug Administration, Enforcement Report (openFDA)retrieved 2026-07-29↩“SEMAGLUTIDE 20mg (5mg/mL), Glycine 20 mg (5mg/mL), 4 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-724-04.”
  10. 10.
    Class II recall D-0756-2026: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type materialU.S. Food and Drug Administration, Enforcement Report (openFDA)retrieved 2026-07-29↩“SEMAGLUTIDE 10mg (5mg/mL), Glycine 10 mg (5mg/mL), 2 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-722-02”
  11. 11.
    Class II recall D-0751-2026: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type materialU.S. Food and Drug Administration, Enforcement Report (openFDA)retrieved 2026-07-29↩“SEMAGLUTIDE 9mg (4.5 mg/mL), 2 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-822-02”
  12. 12.
    Class II recall D-0750-2026: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type materialU.S. Food and Drug Administration, Enforcement Report (openFDA)retrieved 2026-07-29↩“SEMAGLUTIDE 4.5mg (0.9 mg/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-812-03”
  13. 13.
    Class II recall D-0754-2026: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type materialU.S. Food and Drug Administration, Enforcement Report (openFDA)retrieved 2026-07-29↩“SEMAGLUTIDE 5mg (1mg/mL), Glycine 25 mg (5mg/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202.NDC 71170-712-03”
  14. 14.
    FDA Form 483 inspectional observations, Apollo Care LLC, issued 2026-07-28FDAretrieved 2026-07-28↩“reviewed retain samples of Semaglutide Injection and Semaglutide with Glycine Injection drug product vials”
  15. 15.
    FDA: Warning Letter (02/02/2026)U.S. Food and Drug Administration↩
  16. 16.
    FDA: 483 Issued 03/27/2025 (PDF - 2 MB)U.S. Food and Drug Administration↩
  17. 17.
    FDA: 483 Issued 04/05/2023 (PDF - 2 MB)U.S. Food and Drug Administration↩
  18. 18.
    FDA: 483 Issued 09/8/2021 (PDF - 2 MB)U.S. Food and Drug Administration↩
  19. 19.
    FDA: Warning Letter (03/20/2019)U.S. Food and Drug Administration↩
  20. 20.
    Compounding inspections, recalls, and other actionsU.S. Food and Drug Administrationretrieved 2026-11-20↩
  21. 21.
  22. 22.
    Compounding and the FDA: Questions and AnswersU.S. Food and Drug Administration↩
  23. 23.
  24. 24.

A pharmacy’s record can change after the day we read it: check its license with its state board before you fill a prescription. An FDA document is an allegation or an observation the FDA has published, not a court finding. This page is educational and is not medical advice.